SCHEMBL6736314

SCHEMBL6736314

COC(=O)C(Cc1ccc(O)cc1)O[Si](C)(C)C

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 2/20 0.56
ESR2 Q92731 2/20 0.56
MIF P14174 2/20 0.49
KMT2A Q03164 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
PTGS2 P35354 3/20 0.44
ELANE P08246 1/20 0.44
TSHR P16473 1/20 0.43
LNPEP Q9UIQ6 1/20 0.43
MDM4 O15151 1/20 0.43
MDM2 Q00987 1/20 0.43
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
KDR P35968 1/20 0.40
NLRP3 Q96P20 1/20 0.40
SLC7A5 Q01650 1/20 0.40
MMP1 P03956 1/20 0.40
MMP2 P08253 1/20 0.40
MMP3 P08254 1/20 0.40
MMP9 P14780 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6737972 0.86 PTGS2 (0.46) ESR1ESR2MIFPTGS2SLC7A5
SCHEMBL6735869 0.85 ESR1 (0.51) ESR1ESR2MIFKMT2ANPSR1
SCHEMBL6738744 0.85 ESR1 (0.43) ESR1ESR2MIFTSHRSLC7A5
SCHEMBL6737968 0.84 SLC7A5 (0.50) ESR1ESR2SLC7A5
SCHEMBL542969 0.83 ESR1 (0.63) ESR1ESR2MIFKMT2ANPSR1
SCHEMBL5024580 0.83 ESR1 (0.63) ESR1ESR2MIFKMT2ANPSR1
SCHEMBL542970 0.83 ESR1 (0.63) ESR1ESR2MIFKMT2ANPSR1
SCHEMBL3993110 0.79 ESR1 (0.58) ESR1ESR2MIFKMT2ANPSR1
SCHEMBL3535227 0.79 ESR1 (0.58) ESR1ESR2MIFKMT2ANPSR1
SCHEMBL3535230 0.79 ESR1 (0.58) ESR1ESR2MIFKMT2ANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040248849-A1 3-Aryl-A-oxy substituted propanoic acids and a process for their preparation DR. REDDY'S LABORATORIES INC. 2004-12-09 US claimed
WO-2003002575-A1 3-ARYL-$G(a)-OXY SUBSTITUTED PROPANOIC ACIDS AND A PROCESS FOR THEIR PREPARATION DR. REDDY'S LABORATORIES LTD. (IN) 2003-01-09 WO claimed
US-20040248849-A1 3-Aryl-A-oxy substituted propanoic acids and a process for their preparation DR. REDDY'S LABORATORIES INC. 2004-12-09 US disclosed
WO-2003002575-A1 3-ARYL-$G(a)-OXY SUBSTITUTED PROPANOIC ACIDS AND A PROCESS FOR THEIR PREPARATION DR. REDDY'S LABORATORIES LTD. (IN) 2003-01-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040248849-A1 3-Aryl-A-oxy substituted propanoic acids and a process for their preparation GPR119, GLP1R, SLC5A1 ESR1 3084/4885ESR2 1585/4885MIF 2010/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.